Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling

被引:49
|
作者
Gotoh, Tetsuya [1 ]
Vila-Caballer, Marian [1 ]
Liu, Jingjing [1 ]
Schiffhauer, Samuel [1 ]
Finkielstein, Carla V. [1 ]
机构
[1] Virginia Polytech Inst & State Univ, Dept Biol Sci, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA
基金
美国国家科学基金会;
关键词
TUMOR SUPPRESSION; CLOCK; GENE; COMPONENT; MUTATION; PROTEIN; DEGRADATION; EXPRESSION; PLAYS; BMAL1;
D O I
10.1091/mbc.E14-05-0994
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Circadian period proteins influence cell division and death by associating with checkpoint components, although their mode of regulation has not been firmly established. hPer2 forms a trimeric complex with hp53 and its negative regulator Mdm2. In unstressed cells, this association leads to increased hp53 stability by blocking Mdm2-dependent ubiquitination and transcription of hp53 target genes. Because of the relevance of hp53 in checkpoint signaling, we hypothesize that hPer2 association with hp53 acts as a regulatory module that influences hp53's downstream response to genotoxic stress. Unlike the trimeric complex, whose distribution was confined to the nuclear compartment, hPer2/hp53 was identified in both cytosol and nucleus. At the transcriptional level, a reporter containing the hp21(WAF1/CIP1) promoter, a target of hp53, remained inactive in cells expressing a stable form of the hPer2/hp53 complex even when treated with gamma-radiation. Finally, we established that hPer2 directly acts on the hp53 node, as checkpoint components upstream of hp53 remained active in response to DNA damage. Quantitative transcriptional analyses of hp53 target genes demonstrated that unbound hp53 was absolutely required for activation of the DNA-damage response. Our results provide evidence of the mode by which the circadian tumor suppressor hPer2 modulates hp53 signaling in response to genotoxic stress.
引用
收藏
页码:359 / 372
页数:14
相关论文
共 50 条
  • [1] The circadian factor period 2 modulates p53 stability and function in downstream signaling
    Finkielstein, Carla V.
    Gotoh, Tetsuya
    Vila-Cabailer, Marian
    Santos, Cario
    Liu, Jingjing
    Yang, Jianhua
    CANCER RESEARCH, 2013, 73 (08)
  • [2] DNA-DAMAGE, P53 AND ANTICANCER THERAPIES
    MILNER, J
    NATURE MEDICINE, 1995, 1 (09) : 879 - 880
  • [3] The circadian factor Period2 modulates p53 function in unstressed cells
    Finkielstein, Carla V.
    Gotoh, Tetsuya
    Vila-Caballer, Marian
    Santos, Carlo
    Liu, Jingjing
    Yang, Jianhua
    CANCER RESEARCH, 2012, 72
  • [4] P53 AND OTHER MOLECULAR CONTROLS OF THE RESPONSE TO DNA-DAMAGE
    KASTAN, MB
    NELSON, WG
    CHEN, CY
    SLICHENMYER, WB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 164 - 164
  • [5] P53 AND OTHER MOLECULAR CONTROLS OF THE RESPONSE TO DNA-DAMAGE
    KASTAN, MB
    NELSON, WG
    CHEN, CY
    SLICHENMYER, WB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 209 - 209
  • [6] The p53 response to DNA damage
    Meek, DW
    DNA REPAIR, 2004, 3 (8-9) : 1049 - 1056
  • [7] DNA-DAMAGE, ONCOGENESIS AND THE P53 TUMOR-SUPPRESSOR GENE
    LEE, JM
    ABRAHAMSON, JLA
    BERNSTEIN, A
    MUTATION RESEARCH, 1994, 307 (02): : 573 - 581
  • [8] P53 - A CELL-CYCLE REGULATOR ACTIVATED BY DNA-DAMAGE
    SELIVANOVA, G
    WIMAN, KG
    ADVANCES IN CANCER RESEARCH, VOL 66, 1995, 66 : 143 - 180
  • [9] DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
    Blattner, C
    Tobiasch, E
    Litfen, M
    Rahmsdorf, HJ
    Herrlich, P
    ONCOGENE, 1999, 18 (09) : 1723 - 1732
  • [10] DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
    Christine Blattner
    Edda Tobiasch
    Margarethe Litfen
    Hans J Rahmsdorf
    Peter Herrlich
    Oncogene, 1999, 18 : 1723 - 1732